Skip to content

Marsh

US · MRSH #268 by market cap Listed 1970
173.66 +1.92 +1.12%
Live - 5344 symbols - heartbeat 194s ago · 2026-10-08 08:33
Pre-market 173.66 0.00%
After-hours 173.66 0.00%
Overnight 173.68 +0.01%
Market cap
82.87B
P/B
5.46
EPS
8.43
Reader sentiment Are you bullish or bearish on MRSH?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 17 in the most recent period (2026/Q3).
  • Total institutional ownership (as a % of shares) was little changed.

Institutional ownership

Held by institutions
94.71% +0.03pp
Institutions
1,779 -17
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund81.79%
Public Company3.93%
Hedge Fund2.60%
Government Pension Fund2.20%
Private Company1.52%
Sovereign Wealth Fund1.38%
Insurance Company0.57%
Family Office/Trust0.37%
VC/PE Fund0.13%
Other5.52%

Top holders as of 2026-06-30

Capital Research 9.58% · 45.71M sh
BlackRock 8.28% · 39.50M sh
Vanguard Capital Management, LLC 7.16% · 34.18M sh
State Street Global Advisors 4.69% · 22.40M sh
Wellington Management Group 3.56% · 16.98M sh
Other 66.73%
Geode Capital Management, LLC 2.83% · 13.51M sh
T. Rowe Price Group, Inc. 2.82% · 13.46M sh
Vanguard Portfolio Management, LLC 2.63% · 12.57M sh
Harris Associates L.P. 1.82% · 8.69M sh
UBS Asset Management 1.72% · 8.20M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 40 buys · 8 sells

NameRoleStake
John Doyle Chief Executive Officer 0.02%
Steven Mills Independent Director 0.01%
Óscar Fanjul Martín Independent Director 0.01%
Mark McGivney Chief Financial Officer 0.01%
H. Hanway Independent Chairperson 0.01%
Nicholas Studer Vice Chairperson 0.01%
Dean Klisura Vice Chairperson 0.01%
Martin South Vice Chairperson 0.00%
Paul Beswick Chief Information Officer 0.00%
Carmen Fernandez Chief Human Resources Officer 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-01 John Doyle Chief Executive Officer Derivative Exercise and Sale -16,656 $73.20–188.51
2026-09-01 Katherine Brennan Former Senior Vice President Derivative Exercise and Sale -1,197 $83.05–187.90
2026-08-14 Bruce Broussard Director Other Acquisition +192 $188.45
2026-08-14 Steven Mills Independent Director Other Acquisition +194 $188.45
2026-08-14 Morton Schapiro Independent Director Other Derivative Acquisition +692 --
2026-08-14 Lloyd Yates Independent Director Other Derivative Acquisition +288 --
2026-08-14 Jane Lute Independent Director Other Derivative Acquisition +190 --
2026-08-13 Deborah Hopkins Independent Director Other Derivative Acquisition +112 --
2026-08-13 Tamara Ingram Independent Director Other Derivative Acquisition +47 --
2026-08-13 Jan Siegmund Director Other Derivative Acquisition +12 --
2026-08-13 Anthony Anderson Independent Director Other Derivative Acquisition +89 --
2026-08-05 John Jones Chief Marketing and Communications Officer Open Market Disposition -6,500 $191.96
2026-07-28 Paul Beswick Chief Information Officer Automatic Disposition -713 $198.00
2026-07-27 Martin South Vice Chairperson Open Market Disposition -7,100 $189.99
2026-07-22 Lloyd Yates Independent Director Open Market Disposition -12,000 $175.65
2026-06-01 John Doyle Chief Executive Officer Derivative Exercise and Sale -16,656 $73.20–161.71
2026-05-31 H. Hanway Independent Chairperson Other Acquisition +1,349 $159.28
2026-05-31 Deborah Hopkins Independent Director Other Derivative Acquisition +1,349 --
2026-05-31 Peter Harrison Director Sale to Issuer -103 $159.28
2026-05-31 Peter Harrison Director Other Acquisition +1,349 $159.28

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 08:33:29 · For reference only, not investment advice and not tailored to your situation.